Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
2009; Emerald Publishing Limited; Volume: 14; Issue: 4 Linguagem: Inglês
10.1108/cgij.2009.24814dae.004
ISSN1758-6038
Autores Tópico(s)Lipoproteins and Cardiovascular Health
ResumoWeb Table 1: Baseline characteristics of the primary and secondary prevention trials Number of participants Male Age, years Blood pressure (SBP/DBP), mmHg Total cholesterol, mmol/L Current smokers Body mass index, kg/m 2 Diabetes mellitus Hypertension Any vascular disease Primary prevention trials
Referência(s)